The global microfluidics market size reached USD 20.14 Billion in 2021 and is expected to register a revenue CAGR of 16.1% during the forecast period, according to latest analysis by Emergen Research. Rapid technological advancements in the field of microfluidics such as Point-of-Care Testing (PoCT) and In-Vitro Diagnostics (IVD), significant investments in research & development activities, rising demand for microfluidic platforms for early disease detection and pathogen identification, as well as increasing applications of microfluidic platforms in various healthcare industries are factors driving market revenue growth.T [FURL=https://www.emergenresearch.com/request-sample/35]To receive a PDF sample of the report, visit @ [/FURL]
Competitive Landscape:
The latest study provides an insightful analysis of the broad competitive landscape of the global Microfluidics market, emphasizing the key market rivals and their company profiles. A wide array of strategic initiatives, such as new business deals, mergers & acquisitions, collaborations, joint ventures, technological upgradation, and recent product launches, undertaken by these companies has been discussed in the report. The report analyzes various elements of the market’s competitive scenario, such as the regulatory standards and policies implemented across the industry over recent years. Our team of experts has leveraged several powerful analytical tools, such as Porter’s Five Forces analysis and SWOT analysis, to deliver a comprehensive overview of the global Microfluidics market and pinpoint the fundamental growth trends.
Companies Profiles:
Fluidigm Corporation, F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Abbott Laboratories, Thermo Fisher Scientific, Micronit Micro Technologies B.V., Life Technologies Corporation, Danaher Corporation, Illumina Inc., PerkinElmer
Product Type Outlook & Application Areas:
Technology Outlook (Revenue: USD Billion; 2017-2027)
Medical
Non-Medical
Material Outlook (Revenue: USD Billion; 2017-2027)
Silicon
Glass
Polymer
PDMS
Others
Application Outlook (Revenue: USD Billion; 2017-2027)
Lab-on-a-chip
Organs-on-chips
Continuous flow microfluidics
Optofluidics and Microfluidics
Others